# Schedule of Controlled Substances: Proposed Rule: Rescheduling of Buprenorphine From Schedule V to Schedule III
> **Proposed Rule** · Notice of proposed rulemaking. · Published 2002-03-21 · 67 FR 13114
## Document
- **Document number:** 02-6767
- **Category:** scheduling
- **Type:** Proposed Rule
- **Action:** Notice of proposed rulemaking.
- **Citation:** 67 FR 13114
- **Publication date:** 2002-03-21
## Abstract

This proposed rule is issued by the Administrator of the Drug Enforcement Administration (DEA) to increase the regulatory controls placed on buprenorphine by rescheduling buprenorphine from a Schedule V narcotic to a Schedule III narcotic. This proposed action is based on a formal rescheduling recommendation by the Department of Health and Human Services (DHHS) and a DEA review indicating that buprenorphine meets the definition of a Schedule III narcotic. If finalized, this action will impose the regulatory controls and criminal sanctions of a Schedule III narcotic on those person who handle buprenorphine or products containing buprenorphine.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2002/03/21/02-6767/schedule-of-controlled-substances-proposed-rule-rescheduling-of-buprenorphine-from-schedule-v-to)
---
*AI Analytics · CC0 1.0*